HELP BILLIONS LIVE BETTER
— solving disease, aging, and healthcare inequality
A Global-leading AI healthcare capital operations platform
ETHK Labs Inc. (01931.HK) brings over 30 years of IVD distribution experience. Our subsidiary Wisd is the exclusive distributor of Sysmex coagulation products in China and leads the national first-tier coagulation IVD distribution market. Today, the group focuses on AI healthcare capital operations, spanning 5,000+ employees. Through strategic M&A, we scale high-quality care to solve disease, aging, and healthcare inequality so that billions can live better.
M&A is our only lever. We integrate global AI healthcare category leaders and empower them through our three-curve platform and ecosystem collaboration, amplifying the value of every acquisition. This accelerates breakthrough innovations into scalable commercial outcomes and exponential capital uplift, reshaping the value distribution of global healthcare.
Our Business
➢ Three Curves
The core engine behind strategy execution and value amplification.
Explore the Three CurvesETHK Labs Core Values
Grow with value, protect health with responsibility
We believe enduring success is rooted in clear values. We uphold four core beliefs — do the right things, do things right, the right mechanisms, and the right people — guiding every strategic choice, integration, and ecosystem collaboration.
Do the Right Things
Our compass and direction
Do Things more better
Our execution and craftsmanship
Right Mechanisms
Our soil and platform
Right People
Our foundation and source
Latest News
Major signal: ETHK Labs and Chuangye Huikang enter the AI healthcare execution phase
2026-1-21
11 buybacks in November + HK$82.69M: vote of confidence or prelude to a value storm?
2025-12-01
Share buybacks exceed HK$100M this year; ETHK Labs breaks through AI innovation with a stakeholder-first mindset
2025-11-26
ETHK Labs' AI healthcare mission: building healthcare equity on the foundation of independent innovation
2025-11-25